Journal of Alzheimers Disease

Article	Citations
Biomarker-only diagnosis of Alzheimer's disease: Not ready for prime time	118
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	117
Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years	110
The importance of cognitive correlates of plasma amyloid-β 42/40	107
Interleukin-4 promotes the clearance of amyloid-β by monocyte through enhancing the recognition and intracellular processing of amyloid-β	103
Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database	101
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	87
Progress of research and application of non-pharmacologic intervention in Alzheimer's disease	84
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	81
Associating faces with names and meals as a biomarker of early AD in cognitively healthy individuals	77
Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study	76
Acceptability of bispectral Index monitoring in end-of-life care for dementia	71
Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)	67
Natural history and clinical outcomes in patients with Alzheimer's disease–related psychosis by antipsychotic treatment status in the United States	65
Estimating the rates of dementia using administrative data linked to cohort studies	62
Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes	62
New tablet-based screening tool for assessment of cognitive decline in Nigeria	61
Social isolation and social cognition: A cross-sectional analysis	60
The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers	60
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	60
Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology	57
The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC)	51
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	51
Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis	51
The partner paradox: How can we better understand shared cognitive decline in couples?	51

The association between dual sensory impairment and dementia: A systematic review and meta-analysis	50
Research Attitudes Questionnaire scores and retention in a recruitment registry	49
A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study	48
Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease	47
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	47
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	47
Dancing towards speech improvement: Repurposing dance for motor speech deficits in neurodegenerative diseases	45
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	45
Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease	44
Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients	43
Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease	43
Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras	43
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	42
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	41
Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer’s Disease	40
Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases	40
LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer’s Disease	40
Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer’s Disease	40
Unveiling neural activity changes in mild cognitive impairment using microstate analysis and machine learning	40
A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials	39
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk	38
Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project	38
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease	38
Analysis of the Association Between Pathogen Exposure and the Risk of Dementia	37
A Multi-Dimensional Comparison of Alzheimer’s Disease Neurodegenerative Biomarkers	37
Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden	36
Sex and Gender Differences in Environmental Influences on Dementia Incidence in Germany, 2014–2019: An Observational Cohort Study Based on Health Claims Data	36
Dementia Risk Score for a Population in Southern Europe Calculated Using Competing Risk Models	36
Periodontal Disease and Risk of Dementia in Medicare Patients with Hepatitis C Virus	36
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	36
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports	35
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer’s Disease via ITGA5	34
Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology	34
An Elicitation Study to Understand Black, Hispanic, and Male Older Adults’ Willingness to Participate in Alzheimer’s Disease-Focused Research Registries	34
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively He	34
Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer’s Disease	34
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	33
Screening for Cognitive Impairment with the Quick Memory Check: Validation of a Caregiver Administered Cognitive Screen	33
Social Connectivity is Related to Mild Cognitive Impairment and Dementia	33
Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	33
Correlation of the Serum Fatty Acids with Cognitive Function: An NHANES 2011–2014 and Multivariate Mendelian Randomization Analysis	32
Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer’s Disease Continuum: A Retrospective Observational Study	32
Subtle Thyroid Dysfunction Is Not Associated with Cognitive Decline: Results from the ELSA-Brasil	32
Causal Effects of Kidney Function and Chronic Kidney Disease on Alzheimer’s Disease by Analyzing Large-Scale Genome-Wide Association Study Datasets	32
A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders	31
De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer’s Disease Associated with Spasticity: A Case Report	31
Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study	31
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	31
The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer’s Disease Continuum	31
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia	30

Early-Onset Dementia Associated with a Heterozygous, Nonsense, and de novo Variant in the MBD5 Gene	30
Patterns of Mixed Pathologies in Down Syndrome	30
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer’s Disease	30
Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility	30
Cognitive Reserve Modulates Brain Structure and Cortical Architecture in the Alzheimer’s Disease	30
A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study	30
A Cross-National Study of Dementia Stigma Among the General Public in Israel and Australia	30
How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer’s Disease Research and Clinical Practices?	28
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	28
Assessment of Cognitive Symptoms in Brain Bank-Registered Control Subjects: Feasibility and Utility of a Telephone-Based Screening	28
Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults	28
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder	28
Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer’s Disease in People with Down Syndrome	28
A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?	27
Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer’s Disease: A Multivariable Mendelian Randomization Study	27
Circulating Exosomes from Alzheimer’s Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell	27
Associations Between Atrial Arrhythmias and Brain Amyloid Deposition: The ARIC-PET Study	27
The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	27
Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study	27
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis1	27
High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer’s Disease Using [11C]AZD2184	27
Can early gut microbiota screening reduce the incidence of cognitive impairment? A Mendelian randomization study	27
Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer’s Disease: Implications for Treatment	27
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction	27
Erratum Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma	26
Biting the Bullet: Firearm Ownership in Persons with Dementia. A Registry-Based Observational Study	26
Association Between Serum Cystatin C and Cognitive Decline Independently from Creatinine: Evidence from Two Nationally Representative Aging Cohorts	26
Locus Coeruleus Degeneration Differs Between Frontotemporal Lobar Degeneration Subtypes	26
Ethnic Variations in Patient Outcomes in a Memory Clinic Setting Between 2013 and 2021	26
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	26
PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer’s Disease Entorhinal Cortex Revealed with Multiplexed in situ Hybridization	26
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	26
Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer’s Disease in Females	26
Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer’s Disease: A Literature Review from a Machine Learning Perspective	26
Differences in Dementia Care Between Swedish-Born and Foreign-Born from Countries with Different Country Level Socioeconomic Position: A Nationwide Register-Based Study	25
Impact of Long-Term Exposure to Air Pollution on Cognitive Decline in Older Adults Without Dementia	25
Correlation of Blood Metal Concentrations with Cognitive Scores and Neuroimaging Findings in Patients with Total Joint Arthroplasty	25
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	25
Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer’s Disease	25
Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer’s Disease	25
Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease	25
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	25
Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer’s Disease Brain Tissues	25
Erratum to: Cerebrospinal Fluid Sphingomyelins in Alzheimer’s Disease, Neurodegeneration, and Neuroinflammation	25
The Oxytocin Puzzle: Unlocking Alzheimer’s Disease	25
Early-Life Pb Exposure Might Exert Synapse-Toxic Effects Via Inhibiting Synapse-Associated Membrane Protein 2 (VAMP2) Mediated by Upregulation of miR-34b	25
Enhanced Brain Clearance of Tau and Amyloid-β in Alzheimer’s Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF)	25
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	25
Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer’s Disease in a Mouse Model	25
DEF8 and Autophagy-Associated Genes Are Altered in Mild Cognitive Impairment, Probable Alzheimer’s Disease Patients, and a Transgenic Model of the Disease	25
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN Trial	24
Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques	24
Alterations of Neuronal Lysosomes in Alzheimer’s Disease and in APPxPS1-KI Mice	24
Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer’s Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach	24
Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy	24
Disentangling Clinical Profiles of Apathy in Behavioral Variant Frontotemporal Dementia	24
Effects of the Participation and Involvement of Medical Professionals in Dementia Cafés on the Attendance of People with Dementia Living at Home and Their Family Caregivers	24
Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study	24
A Qualitative Study on the Experiences of Therapists Delivering the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) Intervention During the COVID-19 Pandemic	24
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	24
The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease	24
Normative References for Graphomotor and Latency Digital Clock Drawing Metrics for Adults Age 55 and Older: Operationalizing the Production of a Normal Appearing Clock	24
Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study	24
Alzheimer’s Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis	24
Retinal Examinations Provides Early Warning of Alzheimer’s Disease	24
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	24
Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer’s Disease and Neurodegeneration	24
A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change	24
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	24
Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring$	24
Did Reagan Decline?	23
Dementia Research on Facebook and Twitter: Current Practice and Challenges	23
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	23
The Heritability of Subjective Cognitive Complaints in Older Australian Twins	23
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	23
CAIDE Score, Alzheimer’s Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study	23
The Moderating Role of Race and Ethnicity in the Association Between Cognitive Performance and Functional Abilities in Later Life	23
Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer’s Disease, Parkinson’s Disease, and Multiple Sclerosis	23
Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults	23
How Not to Study a Disease: The Story of Alzheimer’s by Karl Herrup, The MIT Press, 2021, 245 pp	23

Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review	23
Language and Meaning: Asymptomatic Alzheimer’s Disease in the Clinic and Society	22
A Data-Driven Cognitive Composite Sensitive to Amyloid-β for Preclinical Alzheimer’s Disease	22
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	22
SHMAD: A Smart Health Care System to Monitor Alzheimer’s Disease Patients	22
The Cognition and Flow Study (CogFlowS): A Mixed Method Evaluation of a Randomized Feasibility Trial of Cognitive Training in Dementia	22
Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition	22
Reduced Vision-Related Quality of Life in Dementia: A Preliminary Report	22
Self- and Other-Evaluation in Alzheimer’s Disease	22
Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer’s Disease Mouse Model (PS1V97L)	22
Understanding Family Caregivers’ Needs in Coping with the Behavioral and Psychological Symptoms of People with Dementia: A Hermeneutic–Phenomenological Study	22
lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer’s Disease Through NEDD4L Mediated PINK1 Degradation	22
Structural Alteration of Gut Microbiota During the Amelioration of Chronic Psychological Stress-Aggravated Diabetes-Associated Cognitive Decline by a Traditional Chinese Herbal Formula, ZiBu PiYin Rec	22
Drosophila as a Model for Microbiota Studies of Neurodegeneration	22
Autonomic Dysfunction Impairs Baroreflex Function in an Alzheimer’s Disease Animal Model	21
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition	21
Testing Visual Binding by the TMA-93 in People Aged 75 and Over	21
White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease	21
Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts	21
Virtual Behavioural Medicine Program: A Novel Model of Care for Neuropsychiatric Symptoms in Dementia1	21
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	21
Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates	21
Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia	21
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments	21
Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review	21
Contactin 5 and Apolipoproteins Interplay in Alzheimer’s Disease	21
Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort	21
Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer’s Disease Pathology in Later Life	21
The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer’s Disease: A Re-Analysis of CATIE-AD	21
Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer’s Disease	21
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	21
Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease	21
Aging-Related Protein Alterations in the Brain	21
Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer’s Disease	21
Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank	21
Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease	21
Effects of Mindful Awareness Practice (MAP) on Subclinical Depressive and Anxiety Symptoms and General Cognitive Function in Older Adults with Mild Cognitive Impairment: A 5-Year Follow-Up of the MAP-	21
Epileptic Seizures in Alzheimer’s Disease: What Are the Implications of SANAD II?	20
Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume	20
The Association of Brain Insulin Resistance with Anesthesia/Surgery-Induced Cognitive Deterioration Is Female-Specific in 5XFAD Transgenic Mice	20
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	20
Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity	20
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	20
Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer’s Disease: A Randomized Pilot Study	20
Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer’s Disease with High Physical Activity	20
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	20
Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB)	20
Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer’s Disease: The JPSC-AD Study	20
Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer’s Disease	20
Identification of the Neural Circuit Underlying Episodic Memory Deficit in Amnestic Mild Cognitive Impairment via Machine Learning on Gray Matter Volume	20
Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study	20
A Randomized Controlled Trial on the Effects of a 6-Month Home-Based Physical Activity Program with Individual Goal-Setting and Volunteer Mentors on Physical Activity, Adherence, and Physical Fitness	20
Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data	20
Efficacy of Glucose Metabolism-Related Indexes on the Risk and Severity of Alzheimer’s Disease: A Meta-Analysis	20
Incident Dementia After Spontaneous Intracerebral Hemorrhage	20
Attentional Control in Subjective Cognitive Decline	20
Body Mass Index Decrease Has a Distinct Association with Alzheimer’s Disease Pathophysiology in APOE ɛ4 Carriers and Non-Carriers	20
Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study	19
Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer’s Disease	19
Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer’s Disease	19
Associations Between Neuroinflammation-Related Conditions and Alzheimer’s Disease: A Study of US Insurance Claims Data	19
Alzheimer’s Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-β Pathology	19
Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?	19
The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment	19
Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitivel	19
Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population	19
Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer’s Disease	19
Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes	19
Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy Bodies	19
Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer’s Disease	19
Metabolic and Vascular Risk Factor Variability Over 25 Years Relates to Midlife Brain Volume and Cognition	19
Reliability of Telephone and Videoconference Methods of Cognitive Assessment in Older Adults with and without Dementia	19
Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer’s Disease Models	19
Association of Age-Related Spontaneous Internal Jugular Vein Reflux with Cognitive Impairment and Incident Dementia	18
Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes	18
Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?	18
Chronic Beneficial Effect of Makeup Therapy on Cognitive Function of Dementia and Facial Appearance Analyzed by Artificial Intelligence Software	18
Aspirin Use and Risk of Alzheimer’s Disease: A 2-Sample Mendelian Randomization Study	18
A Comparison of Operational Definitions for Mild Cognitive Impairment	18
Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia	18
Associations of Diet Quality with Midlife Brain Volume: Findings from the UK Biobank Cohort Study	18
Up Close and Personal with Adult-Onset Leukoencephalopathy	18
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	18
Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study	18
Differentiation of Alzheimer’s Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH D	18
White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI	18
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort	18
Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review	18
Post-Translational Chemical Modification of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal	18
Facets of Personality and Risk of Cognitive Impairment: Longitudinal Findings in a Rural Community from Sardinia	18
Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease	18
Bodily and Visual-Cognitive Navigation Aids to Enhance Spatial Recall in Mild Cognitive Impairment	18
VCAM1 Drives Vascular Inflammation Leading to Continuous Cortical Neuronal Loss Following Chronic Cerebral Hypoperfusion	18
A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology	18
Making the Case for the Accelerated Withdrawal of Aducanumab	18